LimestoneGrey is a specialist R&D tax credit consultancy, working closely with life sciences, med-tech, and biotech companies across the UK, building strong relationships and providing a personal, tailored approach to navigating R&D tax relief.
Watch our Member Showcase Video https://bit.ly/3nDy86q
No data available
No data available
No data available
Macomics is an immuno-oncology company with world-leading expertise in macrophage biology. We are focused on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defense against tumors.
Mandeville Technology Limited provides flexible chief financial officer or finance director services to healthcare and technology companies. Services in the following areas are available: accounting, including audit preparation, financial reporting and management accounts; company secretarial; corporate finance, including deal structuring, disposals, equity funding, financial modelling, mergers and acquisitions, valuations and venture debt; corporate and financial strategy, including budgeting and forecasting, business and financial advice and corporate restructuring; employee incentive schemes, including EMI share options, employee benefit trusts and share purchase schemes; non-executive director; and taxation, including: EIS, R&D tax credits and VAT.
No data available
Marks & Clerk has long been recognised as one of the leading patent, trade mark attorney and intellectual property law firms across the globe, with eight offices across the UK and a further eight in North America and the Asia-Pacific. We offer a comprehensive range of intellectual property services – covering patents, trade marks, designs and copyright. This includes obtaining protection worldwide, portfolio management, strategic and commercial advice, licensing and other contracts, enforcement, due diligence and litigation. . Renowned for our client-led approach, we are a top-tier firm, noted by Legal 500 for our life sciences practitioners and ‘strength in depth.’ From the capture and exploitation of an idea, to the enforcement or defence of rights in disputes Marks & Clerk is your expert partner to ensure your IP is protected and fully exploited. Today’s local is tomorrow’s global – and with our diverse team of practitioners, you’re always supported by a network of experts.
MarshyOS is an AI clarity engine built for high-stakes decision-making in pharma.
It pressure-tests the reasoning behind a decision before it is made, challenging the assumptions a team has stopped questioning and surfacing the risks, gaps and weak points that would otherwise go unexamined. Rather than helping a user toward the answer they already favour, it is designed to interrogate that thinking and show where it is most likely to be wrong.
The focus is pharma diligence in its full context: the science behind an asset or pipeline decision, together with the financial and legal dimensions that sit alongside it in licensing, partnership and M&A activity. These are decisions where the cost of an overlooked risk is significant and lasting, and where the thinking that precedes them is rarely tested with much rigour.
The result is a team that has confronted the strongest challenge to its own position before entering the room, and can commit to a decision it has properly stress-tested.
Confidentiality is fundamental to the product. Conversations are not stored, and the underlying models do not train on user data.
It pressure-tests the reasoning behind a decision before it is made, challenging the assumptions a team has stopped questioning and surfacing the risks, gaps and weak points that would otherwise go unexamined. Rather than helping a user toward the answer they already favour, it is designed to interrogate that thinking and show where it is most likely to be wrong.
The focus is pharma diligence in its full context: the science behind an asset or pipeline decision, together with the financial and legal dimensions that sit alongside it in licensing, partnership and M&A activity. These are decisions where the cost of an overlooked risk is significant and lasting, and where the thinking that precedes them is rarely tested with much rigour.
The result is a team that has confronted the strongest challenge to its own position before entering the room, and can commit to a decision it has properly stress-tested.
Confidentiality is fundamental to the product. Conversations are not stored, and the underlying models do not train on user data.